TAD 2500 helps support immune response, especially in clients undergoing stressful routines or aesthetic treatments
About CagriSema CagriSema is a new treatment for overweight and obesity
Beyond hormonal changes, several interconnected factors may contribute to perimenopausal weight gain: Metabolic slowdown : Basal metabolic rate naturally decreases with age, meaning the body burns fewer calories at rest Muscle mass loss : Sarcopenia (age-related muscle loss) accelerates during perimenopause, further reducing metabolic rate Sleep disruption : Night sweats and insomnia, common perimenopausal symptoms, interfere with hormones regulating appetite and glucose metabolism Mood changes : Anxiety, depression, and stress during this transition may lead to emotional eating patterns Reduced physical activity : Fatigue, joint pain, and other symptoms may decrease exercise tolerance Research suggests women may gain weight gradually during perimenopause, though individual experiences vary considerably
Biochimica et Biophysica Acta (BBA) - General Subjects , 1830(5), 32893303
There was no statistical significance noted in comparing GLP-1 RA users to SGLT-2i users.(7) Table 1 : Comparison of Studies Assessing GLP-1 RA Use Abbreviations: aHR, adjusted hazard ratio
Never shake a reconstituted peptide vial
